Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET
Press release 2020-06-18
Xspray Pharma (Nasdaq Stockholm: XSPRAY) will host a virtual Capital Market Day on June 25 at 14.00-15.30 CET. Theme of the day will be how Xspray's product candidate HyNap-Dasa can pave the way for a number of followers based on the company's technology platform. The Capital Markets Day can be seen via Xspray's website: www.xspraypharma.com.
CEO Per Andersson will present Xspray's operations and the remaining development steps for HyNap-Dasa, the company's leading product candidate, until the expected submission of the ANDA application. Furthermore, Xspray's existing and potential portfolio of amorphous protein kinase inhibitors will be highlighted as well as various scenarios for how these can reach the market. VP Intellectual Property Christer Hällgren and CFO Kerstin Hasselgren will also participate in the meeting, as well as external guests with relevant experience and knowledge of this specific market.
The meeting, moderated by Charlotte Stjerngren at Cord Communications, will end with a Q&A session and studio discussion joined by external market commentators. It will be possible to submit questions to the company during the presentations via e-mail to firstname.lastname@example.org. The meeting will be held in English.
The Capital Markets Day can be seen via Xspray's website: www.xspraypharma.com.
Questions can be sent to: email@example.com.
Welcome on June 25!